Humanized anti-CD3 specific antibodies
US5585097A · kind A · utility
169Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 1993 |
| Grant date | Dec 17, 1996 |
| Priority date | — |
| Expiry date | Nov 8, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.